SCHEMBL29910041

SCHEMBL29910041

CNS(=O)(=O)c1ccc(S(N)(=O)=O)c(O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.51
TSHR P16473 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.47
SERPINE1 P05121 1/20 0.47
PTGES2 Q9H7Z7 1/20 0.46
ALDH1A1 P00352 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
GAA P10253 1/20 0.46
CA2 P00918 5/20 0.44
CA12 O43570 4/20 0.44
CA1 P00915 4/20 0.44
CA9 Q16790 3/20 0.44
CA3 P07451 2/20 0.44
CA4 P22748 2/20 0.44
CA6 P23280 2/20 0.44
CA5A P35218 2/20 0.44
CA7 P43166 2/20 0.44
CA13 Q8N1Q1 2/20 0.44
CA14 Q9ULX7 2/20 0.44
CA5B Q9Y2D0 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23320079 1.00 LMNA (0.51) LMNATSHRL3MBTL1SERPINE1PTGES2
SCHEMBL9143971 0.81 SERPINE1 (0.70) LMNATSHRL3MBTL1SERPINE1ALDH1A1
SCHEMBL28650672 0.80 CA2 (0.49) LMNAL3MBTL1PTGES2ALDH1A1SMN1; SMN2
SCHEMBL23320021 0.80 LMNA (0.46) LMNATSHRL3MBTL1PTGES2ALDH1A1
SCHEMBL7151344 0.80 LMNA (0.49) LMNATSHRL3MBTL1SERPINE1ALDH1A1
SCHEMBL29910026 0.78 L3MBTL1 (0.47) LMNATSHRL3MBTL1PTGES2ALDH1A1
SCHEMBL24115998 0.78 L3MBTL1 (0.47) LMNATSHRL3MBTL1PTGES2ALDH1A1
SCHEMBL23319834 0.78 CA2 (0.58) LMNATSHRL3MBTL1PTGES2ALDH1A1
SCHEMBL17471523 0.77 VCAM1 (0.55) LMNAL3MBTL1PTGES2ALDH1A1SMN1; SMN2
SCHEMBL6933412 0.76 GAA (0.63) LMNATSHRL3MBTL1SERPINE1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220267276-A1 NLRP MODULATORS NOVARTIS INFLAMMASOME RESEARCH, INC. 2022-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220267276-A1 NLRP MODULATORS NLRP1, NRP1, NR4A3 LMNA 3703/4885TSHR 2357/4885L3MBTL1 4865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.